Seeing Is Believing
Currently out of the existing stock ratings of Alexander Nowak, 87 are a BUY (84.47%), 14 are a HOLD (13.59%), 2 are a SELL (1.94%).
Analyst Alexander Nowak, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 43.65% that have a potential upside of 52.86% achieved within 144 days.
Alexander Nowak’s has documented 226 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CVRX, CVRx at 11-Jul-2024.
Analyst best performing recommendations are on CDNA (CAREDX).
The best stock recommendation documented was for CDNA (CAREDX) at 5/1/2024. The price target of $15 was fulfilled within 13 days with a profit of $5.82 (63.4%) receiving and performance score of 48.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
16
$-2.09 (-11.55%)
14
9 days ago
3/7 (42.86%)
$-2.3 (-12.57%)
157
Hold
1 months 25 days ago
6/6 (100%)
$5.95 (12.13%)
165
Buy
12
2 months 13 days ago
3/11 (27.27%)
$2.34 (24.22%)
68
Buy
18
$-0.09 (-0.50%)
10
2 months 13 days ago
4/6 (66.67%)
$3.02 (20.16%)
48
Hold
15
$-3.09 (-17.08%)
9
2 months 25 days ago
9/14 (64.29%)
$5.82 (63.40%)
81
Which stock is Alexander Nowak is most bullish on?
Which stock is Alexander Nowak is most reserved on?
What Year was the first public recommendation made by Alexander Nowak?